Early data from the ADAPT JR trial suggest efgartigimod may benefit adolescents with generalized myasthenia gravis, a rare ...

PHM continues to advance with diverse research impacting clinical care, quality improvement, and health equity. The top 10 ...

A 70-year-old man presented to Tufts emergency department with a 2-day history of left eye redness and periorbital swelling ...

ROCHESTER HILLS, Mich. - Wrangling three children with autism consumed Dana Paduchowski’s days in a chaotic swirl, her weeks ...

Detailed price information for Solid Biosciences Inc (SLDB-Q) from The Globe and Mail including charting and trades.

Ad hoc announcement pursuant to Art. 53 LR Allschwil, Switzerland, November 04, 2025 Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a ...

The Children's Dream Foundation (CDF) recently announced its 2025 grant awards to support the ever-growing medical needs of children in ...

By age group, the pediatric segment is expected to grow at the fastest ... they are exploring safer and more convenient ...

Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX), a specialty pharmaceutical company, announced today that its product portfolio of FDA-approved brands delivered combined net revenues of $8.3 million ...

Renal Cell Carcinoma (RCC): FDA approved oral Everolimus for advanced RCC after failure of sunitinib and/or sorafenib. Approval was based on RECORD-1 randomized phase III (everolimus 10 mg PO daily vs ...